非典型抗精神病药诱发代谢综合征和加重认知障碍相关机制的研究进展
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金项目(32170649,81801323)


Research progress on the mechanism of atypical antipsychotics inducing metabolic syndrome and aggravating cognitive impairment
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    认知障碍是精神分裂症的核心症状。非典型抗精神病药物治疗容易诱发患者的代谢综合 征,而代谢综合征又可进一步加重患者的认知障碍。引起以上临床表现的内在机制主要包括脑源性神 经因子机制、胰岛素抵抗机制、肠道菌群机制、免疫炎症机制和微血管病变机制。基于非典型抗精神病 药物、代谢综合征和认知障碍之间存在复杂联系,现就 3 者的关系及已发现的生物学机制予以综述。

    Abstract:

    Cognitive impairment is the core symptom of schizophrenia. Atypical antipsychotics treatment can easily induce metabolic syndrome in patients, and metabolic syndrome can further aggravate their cognitive impairment. The internal mechanisms causing this series of clinical symptoms mainly include the following: brain-derived neurotrophic factor mechanism, insulin resistance mechanism, intestinal flora mechanism, immune inflammation mechanism and micro vasculopathy mechanism. Based on the complicated relationship among atypical antipsychotics, metabolic syndrome and cognitive impairment, this article reviews the correlation among them and the related biological mechanisms that have been discovered.

    参考文献
    相似文献
    引证文献
引用本文

伊思敏,翁飞鸿,王婷云,魏少卿,李申,时文涛.非典型抗精神病药诱发代谢综合征和加重认知障碍相关机制的研究进展[J].神经疾病与精神卫生,2022,22(12).
DOI :10.3969/j. issn.1009-6574.2022.12.010.

复制
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-02-17